These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 3534568)

  • 41. Pneumococcal vaccine failures. Two case reports and review.
    Sumaya CV; Harbison RW; Britton HA
    Am J Dis Child; 1981 Feb; 135(2):155-8. PubMed ID: 7468549
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy of pneumococcal vaccination in adults. A meta-analysis of randomized controlled trials.
    Fine MJ; Smith MA; Carson CA; Meffe F; Sankey SS; Weissfeld LA; Detsky AS; Kapoor WN
    Arch Intern Med; 1994 Dec 12-26; 154(23):2666-77. PubMed ID: 7993150
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased risk of pneumococcal infections in cardiac transplant recipients.
    Amber IJ; Gilbert EM; Schiffman G; Jacobson JA
    Transplantation; 1990 Jan; 49(1):122-5. PubMed ID: 2301002
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Untreated pneumococcal bacteraemia of cryptic origin in the human adult with spontaneous recovery.
    Austrian R
    S Afr Med J; 1986 Oct; Suppl():46-9. PubMed ID: 3535120
    [No Abstract]   [Full Text] [Related]  

  • 45. Resolving the pneumococcal vaccine controversy: are there alternatives to randomized clinical trials?
    Clemens JD; Shapiro ED
    Rev Infect Dis; 1984; 6(5):589-600. PubMed ID: 6390636
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Should patients with chronic obstructive pulmonary disease be vaccinated against pneumococcal diseases?
    Gaillat J
    Expert Rev Respir Med; 2009 Dec; 3(6):585-96. PubMed ID: 20477349
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prospectus: the prevention of bacteremic pneumococcal pneumonia. A conservative appraisal of vaccine intervention.
    Kaiser AB; Schaffner W
    JAMA; 1974 Oct; 230(3):404-8. PubMed ID: 4153448
    [No Abstract]   [Full Text] [Related]  

  • 48. Pneumococcal vaccine and HIV infection: report of a vaccine failure and reappraisal of its value in clinical practice.
    Willocks LJ; Vithayathil K; Tang A; Noone A
    Genitourin Med; 1995 Apr; 71(2):71-2. PubMed ID: 7744416
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pneumococcal vaccination in patients with chronic renal disease and renal allograft recipients.
    Cosio FG; Giebink GS; Le CT; Schiffman G
    Kidney Int; 1981 Aug; 20(2):254-8. PubMed ID: 6169871
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dairy proteins and the response to pneumovax in senior citizens: a randomized, double-blind, placebo-controlled pilot study.
    Freeman SL; Fisher L; German JB; Leung PS; Prince H; Selmi C; Naguwa SM; Gershwin ME
    Ann N Y Acad Sci; 2010 Mar; 1190():97-103. PubMed ID: 20388140
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A controlled study of pneumococcal polysaccharide vaccine in systemic lupus erythematosus.
    Klippel JH; Karsh J; Stahl NI; Decker JL; Steinberg AD; Schiffman G
    Arthritis Rheum; 1979 Dec; 22(12):1321-5. PubMed ID: 42410
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pneumococcal vaccine in the hospital. Improved use and implications for high-risk patients.
    Klein RS; Adachi N
    Arch Intern Med; 1983 Oct; 143(10):1878-81. PubMed ID: 6354122
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pneumococcal vaccine prevents death from acute lower-respiratory-tract infections in Papua New Guinean children.
    Riley ID; Lehmann D; Alpers MP; Marshall TF; Gratten H; Smith D
    Lancet; 1986 Oct; 2(8512):877-81. PubMed ID: 2876325
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Randomised trial of intravenous immunoglobulin as prophylaxis against infection in plateau-phase multiple myeloma. The UK Group for Immunoglobulin Replacement Therapy in Multiple Myeloma.
    Chapel HM; Lee M; Hargreaves R; Pamphilon DH; Prentice AG
    Lancet; 1994 Apr; 343(8905):1059-63. PubMed ID: 7909099
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pneumococcal immunization in adult diabetics.
    Lederman MM; Schiffman G; Rodman HM
    Diabetes; 1981 Feb; 30(2):119-21. PubMed ID: 7202857
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Protective efficacy of an inactivated Mycoplasma pneumoniae vaccine.
    Wenzel RP; Craven RB; Davies JA; Hendley JO; Hamory BH; Gwaltney JM
    J Infect Dis; 1977 Aug; 136 Suppl():S204-7. PubMed ID: 894086
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adverse reactions to polyvalent pneumococcal vaccine.
    Pönkä A; Leinonen M
    Scand J Infect Dis; 1982; 14(1):67-71. PubMed ID: 7071529
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Epidemiology and development of prophylaxis of acute respiratory diseases and pneumonias in servicemen in modern conditions].
    Zhogolev SL; Ogarkov PI; Zhogolev KD; Udal'tsov OE; Shipitsin KS; Zharkov DA
    Voen Med Zh; 2010 Oct; 331(10):46-53. PubMed ID: 21254584
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Survey of physician acceptance of the pneumococcal vaccine.
    Berk SL; Verghese A; Berk ML; Dison C; Smith JK
    South Med J; 1984 Apr; 77(4):450-4. PubMed ID: 6710200
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Indirect immunofluorescence reaction study of systemic and local humoral immunity in patients with chronic inflammatory lung disease. I. Serological study results with Streptococcus pneumoniae autostrains].
    Vishniakova LA; Veselova TA; Dzharak'ian OT
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Dec; (12):39-43. PubMed ID: 7036606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.